Trademarkia Logo

Canada

C$
Trademark Search in Canada
HEALTH, PLANET & OUR COMMITMENT (& DESIGN)
HEALTH, PLANET & OUR COMMITMENT (& DESIGN)
FORMALIZED

on 23 Aug 2024

Last Applicant/ Owned by

FINCHLEY RESEARCH & DEVELOPMENT INC.

6111 Royalmount AvenueSuite 100Montreal

QUEBEC

CA

H4P2T4

Serial Number

2345633 filed on 23rd Aug 2024

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

HEALTH, PLANET & OUR COMMITMENT (& DESIGN)

Trademark usage description

pharmaceutical preparations and substances for the treatment of inner ear diseases, disorders and infections; pharmaceutical preparations for the pre Read More

Vienna Information


26 . 4 . 5

One quadrilateralUn quadrilatère

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 14

One leafUne feuille

26 . 4 . 2

RectanglesRectangles

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Analgesics; androgen preparations; anti-inflammatories; antiarrhythmic agents; antibacterials; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antihistamines; antihypertensives; antineoplastic agents for bladder cancer instillation; antipyretics; antiseptics; antivirals; anxiolytics; corticosteroids; cough syrups; diarrhea medication; diuretics; enema preparations; germicides; human pharmaceuticals for treatment of cancer; laxatives; medicated dental rinses; medicinal hair growth preparations; muscle relaxants; nausea treatment preparations; opioid antagonist pharmaceutical preparations; oral contraceptives; pain relief medication; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for controlling cholesterol; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of iron deficiency and anemia in humans; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; pharmaceutical preparations for the prevention and treatment of thrombosis; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment and the prevention of dementia; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for treating high cholesterol; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for the treatment of erectile dysfunction; potassium preparations for pharmaceutical purposes; sedatives; stool softeners; thyroid and parathyroid hormone preparations; tumor suppressing agents


Classification kind code

12

Mark Details


Serial Number

2345633

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 5th Sept 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 23rd Aug 2024
Filed
Submitted for opposition 1
on 23rd Aug 2024
Created
Submitted for opposition 31
on 23rd Aug 2024
Formalized